- US12435150utility2025Anti-cd40 Antibodies for Use in Treatment of Hidradenitis Suppurativa0 cites
- US12419894utility2025Ribociclib Tablet0 cites
- US12419889utility2025Methods of Treating Chronic Spontaneous Urticaria Using a Bruton's Tyrosine Kinase Inhibitor0 cites
- US12421223utility2025Compounds and Compositions for Treating Conditions Associated with NLRP Activity0 cites
- USD1092724design2025Medical Autoinjector Device0 cites
- US12410255utility2025Natriuretic Peptide Receptor 1 Antibodies and Methods of Use0 cites
- US12404261utility2025Compounds and Compositions for Treating Conditions Associated with Cgas0 cites
- US12383601utility2025Chimeric Antigen Receptors and Uses Thereof0 cites
- US12383556utility2025Methods of Treating Sjögren's Syndrome Using a Bruton's Tyrosine Kinase Inhibitor0 cites
- US12384758utility2025Crystalline Form of LNP0230 cites
- US12378206utility2025Heteroaryl Butanoic Acid Derivatives0 cites
- US12378222utility2025NLRP3 Inflammasome Inhibitors0 cites
- US12371481utility2025Methods for Treating Age-related Macular Degeneration0 cites
- US12371510utility2025Process for Concentration of Antibodies and Therapeutic Products Thereof0 cites
- US12358906utility2025Urea Compounds and Compositions as SMARCA2/BRM Atpase Inhibitors0 cites
- US12357630utility2025Ceritinib Formulation0 cites
- US12358929utility2025NMDA Receptor Modulators and Uses Thereof0 cites